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Abstract 
Different anesthetic techniques have been suggested for craniotomy with intraoperative awakening. 
We describe an asleep-awake-asleep technique with propofol and remifentanil infusions, with 
pharmacokinetic simulation to predict the effect-site concentrations and to modulate the infusion 
rates of both drugs, and bispectral index (BIS) monitoring. Five critical moments were defined: first 
loss of consciousness (LOC1), first recovery of consciousness (ROC1), final of neurologic testing (NT), 
second loss of consciousness (LOC2), and second recovery of consciousness (ROC2). At LOC1, 
predicted effect-site concentrations of propofol and remifentanil were, respectively, 3.6±1.2 μg/mL 
and 2.4±0.4 ηg/mL. At ROC1, predicted effect-site concentrations of propofol and remifentanil were, 
respectively, 2.1±0.3 μg/mL and 1.8±0.3 ηg/mL. At NT, predicted effect-site concentrations of 
propofol and remifentanil were, respectively, 0.9±0.3 μg/mL and 1.8±0.2 ηg/mL. At LOC2, predicted 
effect-site concentrations of propofol and remifentanil were, respectively, 2.1±0.2 μg/mL and 2.5±0.2 
ηg/mL. At ROC2, predicted effect-site concentrations of propofol and remifentanil were, respectively, 
1.2±0.5 μg/mL and 1.4±0.2 ηg/mL (data are mean±SE). A significative correlation was found between 
BIS and predicted effect-site concentrations of propofol (r2=0.547, P<0.001) and remifentanil 
(r2=0.533, P<0.001). Multiple regression analysis between BIS and propofol and remifentanil 
predicted effect-site concentrations at the different critical steps of the procedure was done and found 
also significative (r2=0.7341, P<0.001). 
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